GLT8D2 and metabolic dysfunction-associated steatotic liver disease: It has previously been reported that GLT8D2 participated in NAFLD pathogenesis via negatively regulating MTP in HepG2 cells [24], but the biological function and molecular mechanism of GLT8D2 in chemoresistance remain unclear.